Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.

A role for glucagon-like peptide-1 in the central regulation of feeding

Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci990 · Cited by 1,402

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124

Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans

Ørskov, C., Rabenhøj, L., Wettergren, A., Kofod, H., & Holst, J. J. (1994) · Diabetes · doi:10.2337/diab.43.4.535 · Cited by 916

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans

Nauck, M. A., Niedereichholz, U., Ettler, R., Holst, J. J., Ørskov, C., Ritzel, R. A., & Schmiegel, W. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.5.e981 · Cited by 834

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene

Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793

Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man

Wettergren, A., Schjoldager, B., Mortensen, P. E., Myhre, J., Christiansen, J., & Holst, J. J. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01316798 · Cited by 670

Hamster preproglucagon contains the sequence of glucagon and two related peptides

Bell, G. I., Santerre, R. F., & Mullenbach, G. T. (1983) · Nature · doi:10.1038/302716a0 · Cited by 649

Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats

Tang-Christensen, M., Larsen, P. J., Goke, R., Fink-Jensen, A., Jessop, D. S., Moller, M., & Sheikh, S. P. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.4.r848 · Cited by 597

Attenuated GLP-1 secretion in obesity: cause or consequence

Ranganath, L. R., Beety, J. M., Morgan, L. M., Wright, J. W., Howland, R., & Marks, V (1996) · Gut · doi:10.1136/gut.38.6.916 · Cited by 394

Lipids in health and disease

Finkelstein, J. M., Heemels, M.-T., Shadan, S., & Weiss, U. K. (2014) · Nature · doi:10.1038/510047a · Cited by 41

Activity-induced GLP-1 release in lean and obese subjects

Adam, T. C., & Westerterp‐Plantenga, M. S. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.08.035 · Cited by 39

Plasticity of gastrointestinal vagal afferent satiety signals

Page, A. J., & Kentish, S. J. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12973 · Cited by 39

The effect of a medium-term activity- and diet-induced energy deficit on subjective appetite sensations in obese children

King, N. A., Hester, J., & Gately, P. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803391 · Cited by 38

Pro-protein convertases in intermediary metabolism: islet hormones, brain/gut hormones and integrated physiology

BATAILLE, D. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0167-4 · Cited by 39

The gut and food intake: an update for surgeons

Näslund, E. B., Hellström, P. M., & Kral, J. G. (2001) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(01)80095-0 · Cited by 36

Carbohydrate and Satiety

Feinle, C., O’Donovan, D., & Horowitz, M. (2002) · Nutrition Reviews · doi:10.1301/002966402320243241 · Cited by 36

Incretin Therapies: Effects Beyond Glycemic Control

Mudaliar, S. R. D., & Henry, R. R. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.03.014 · Cited by 35

A genome-wide association study of energy intake and expenditure

Jiang, L., Penney, K. L., Giovannucci, E. L., Kraft, P. L., & Wilson, K. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201555 · Cited by 34

Implementation of GLP-1 Based Therapy of Type 2 Diabetes Mellitus Using DPP-IV Inhibitors

Holst, J. J. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47920-6_33 · Cited by 36

Harnessing the Therapeutic Potential of Glucagon-Like Peptide-1

Baggio, L. L., & Drucker, D. J. (2002) · Treatments in Endocrinology · doi:10.2165/00024677-200201020-00005 · Cited by 35

An isocaloric increase of eating episodes in the morning contributes to decrease energy intake at lunch in lean men

Allirot, X., Saulais, L., Seyssel, K., Graeppi-Dulac, J., Roth, H., Charrié, A., Drai, J., Goudable, J., Blond, E., Disse, E., et al. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.01.009 · Cited by 39

Bariatric surgery – time to replace with GLP-1?

Webb, D., Abrahamsson, N., Sundbom, M., & Hellström, P. M. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1293154 · Cited by 38

Lymphatics in intestinal transport of nutrients and gastrointestinal hormones

Kohan, A. B., Yoder, S. M., & Tso, P. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05753.x · Cited by 33

Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus

Yan, P., Li, L., Yang, M., Liu, D., Liu, H., Boden, G. H., & Yang, G. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.02.030 · Cited by 33

Impact of Gastric Bypass Surgery on Gut Hormones and Glucose Homeostasis in Type 2 Diabetes

Näslund, E. B., & Kral, J. G. (2006) · Diabetes · doi:10.2337/db06-s012 · Cited by 33

Gut Hormones Ghrelin, PYY, and GLP-1 in the Regulation of Energy, Balance, and Metabolism

Pérez–Tilve, D., Nogueiras, R., Mallo, F., Benoit, S. C., & Tschoep, M. H. (2006) · Endocrine · doi:10.1385/endo:29:1:61 · Cited by 33

Pharmacological Targeting of Glucagon and Glucagon-Like Peptide 1 Receptors Has Different Effects on Energy State and Glucose Homeostasis in Diet-Induced Obese Mice

Gu, W., Lloyd, D. J., Chinookswong, N., Komorowski, R., Sivits, G. N., Graham, M., Winters, K. A., Yan, H., Boros, L. G., Lindberg, R. A., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.179986 · Cited by 32

Gut hormones: the future of obesity treatment?

McGavigan, A. K., & Murphy, K. G. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04278.x · Cited by 31

Additive Effects of Glucagon-Like Peptide 1 and Pioglitazone in Patients With Type 2 Diabetes

Zander, M., Christiansen, A. L., Madsbad, S., & Holst, J. J. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1910 · Cited by 32

Using the lymphatics to study nutrient absorption and the secretion of gastrointestinal hormones

Kohan, A. B., Yoder, S. M., & Tso, P. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.056 · Cited by 32

The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes

Rohde, U., Federspiel, C. A., Vilmann, P., Langholz, E., Friis, S., Krakauer, M., Rehfeld, J. F., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12800 · Cited by 30

Role of gastrointestinal hormones in feeding behavior and obesity treatment

Kairupan, T. S., Amitani, H., Cheng, K., Runtuwene, J., Asakawa, A., & Inui, A. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1118-4 · Cited by 29

Pharmacokinetics and Pharmacodynamics of Liraglutide, a Long‐Acting, Potent Glucagon‐Like Peptide‐1 Analog

Meece, J. D. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.pt2.33s · Cited by 32

GLP-1: Broadening the incretin concept to involve gut motility

Hellström, P. M. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.04.004 · Cited by 30

Gastric stimulation for weight loss

Mizrahi, M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i19.2309 · Cited by 30

Management of type 2 diabetes: the role of incretin mimetics

Stonehouse, A. H., Holcombe, J. H., & Kendall, D. M. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.15.2095 · Cited by 29

Safety and Efficacy of Dulaglutide, a Once Weekly GLP-1 Receptor Agonist, for the Management of Type 2 Diabetes

Kuritzky, L., Umpierrez, G. E., Ekoé, J. M., Mancillas‐Adame, L. G., & Landó, L. F. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.10.2821 · Cited by 30

What is Obesity?

Purnell, J. Q. (2023) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2023.03.001 · Cited by 32

Birth weight and the Metabolic Syndrome: thrifty phenotype or thrifty genotype?

Stern, M. P., Bartley, M., Duggirala, R., & Bradshaw, B. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(200003/04)16:2 · Cited by 65

Effects of a Preload on Reduction of Food Intake by GLP-1 in Healthy Subjects

Degen, L. P., Oesch, S., Matzinger, D., Drewe, J., Knupp, M., Zimmerli, F., & Beglinger, C. (2006) · Digestion · doi:10.1159/000097585 · Cited by 29

National survey of pediatric fever management practices among emergency department nurses.

Thomas, V., Riegel, B. J., Andrea, J., Murray, P., Gerhart, A. E., & Gocka, I. (1994) · PubMed · Cited by 27

Lower glucose-dependent insulinotropic polypeptide (GIP) response but similar glucagon-like peptide 1 (GLP-1), glycaemic, and insulinaemic response to ancient wheat compared to modern wheat depends on processing

Bakhøj, S., Flint, A., Holst, J. J., & Tetens, I. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601680 · Cited by 27

In support of an early polypharmacy approach to the treatment of type 2 diabetes

Wright, E. E., Stonehouse, A. H., & Cuddihy, R. M. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01255.x · Cited by 27

Glucagon-like peptide-1: physiology and therapeutic potential

Holst, J. J. (2005) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000151395.52819.47 · Cited by 27

Antidiabetogenic action of glucagon‐like peptide‐1 related to administration relative to meal intake in subjects with type 2 diabetes

Gutniak, M., Svartberg, J. B., Hellström, P. M., Holst, J. J., Adner, N., & Åhrén, B. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00862.x · Cited by 27

The interplay of glucose-dependent insulinotropic polypeptide in adipose tissue

Kagdi, S., Lyons, S. A., & Beaudry, J. L. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0361 · Cited by 29

Effect of dietary macronutrients on postprandial incretin hormone release and satiety in obese and normal-weight women

Wikarek, T., Chudek, J. T., Owczarek, A. J., & Olszanecka‐Glinianowicz, M. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513002389 · Cited by 26

The capsaicin analog nonivamide decreases total energy intake from a standardized breakfast and enhances plasma serotonin levels in moderately overweight men after administered in an oral glucose tolerance test: A randomized, crossover trial

Hochkogler, C. M., Lieder, B., Hojdar, K., Pignitter, M., Widder, S., Ley, J. P., Krammer, G. E., & Somoza, V. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300821 · Cited by 26

Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders

Vadnie, C. A., Park, J. H., Gawad, N. A., Ho, A. M., Hinton, D. J., & Choi, D. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00288 · Cited by 26

Arcuate Nucleus Transcriptome Profiling Identifies Ankyrin Repeat and Suppressor of Cytokine Signalling Box‐Containing Protein 4 as a Gene Regulated by Fasting in Central Nervous System Feeding Circuits

Li, J., Kuick, R. D., Thompson, R. C., Misek, D. E., Lai, Y. ‐., Yun-Qiang, L. I. U., Chai, B.-X., Hanash, S., & Gantz, I. (2005) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2005.01317.x · Cited by 26

Gastrointestinal peptides in eating-related disorders

Smith, K., & Moran, T. H. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113456 · Cited by 25

GLP‐1 playing the role of a gut regulatory compound

Hellström, P. M. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02150.x · Cited by 25

The spectrum of antidiabetic actions of GLP-1 in patients with diabetes

Vilsbøll, T., Holst, J. J., & Knop, F. K. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.03.011 · Cited by 23

Liraglutide in the treatment of obesity

Ng, S. Y. A., & Wilding, J. P. H. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.925870 · Cited by 26

GLP-1 receptor agonists and weight loss in schizophrenia – past, present, and future

Trott, M., Arnautovska, U., & Siskind, D. J. (2024) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000952 · Cited by 23

Differential Effects of Monounsaturated and Polyunsaturated Fats on Satiety and Gut Hormone Responses in Healthy Subjects

Sun, L., Goh, H. J., Govindharajulu, P., Leow, M. K., & Henry, C. J. (2019) · Foods · doi:10.3390/foods8120634 · Cited by 23

Physiology, pathophysiology and therapeutic implications of enteroendocrine control of food intake

Elliott, J. A., Reynolds, J. V., le Roux, C. W., & Docherty, N. G. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2016.1245140 · Cited by 22

Gastric Inhibitory Polypeptide Analogues

Holst, J. J. (2002) · BioDrugs · doi:10.2165/00063030-200216030-00002 · Cited by 22

Promising New Approaches to the Management of Obesity

Mertens, I. L., & Gaal, L. F. V. (2000) · Drugs · doi:10.2165/00003495-200060010-00001 · Cited by 21

Glucagon-like peptide-1 analogue LY315902: Effect on intestinal motility and release of insulin and somatostatin

Näslund, E. B., Skogar, S., Efendić, S., & Hellström, P. M. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00054-x · Cited by 22

Local, exendin-(9—39)-insensitive, site of action of GLP-1 in canine ileum

Daniel, E. E., Anvari, M., Fox-Threlkeld, J.-A. E. T., & McDonald, T. J. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00110.2002 · Cited by 22

Targeting skeletal muscle mitochondrial health in obesity

Pileggi, C. A., Hooks, B. G., McPherson, R., Dent, R. R. M., & Harper, M.-E. (2022) · Clinical Science · doi:10.1042/cs20210506 · Cited by 21

Gut Hormones and Obesity

Scott, R., Tan, T., & Bloom, S. R. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00007-9 · Cited by 20

Incretin mimetics and dipeptidyl peptidase-4 inhibitors: innovative treatment therapies for type 2 diabetes

Davidson, J. A., Parente, E. B., & Gross, J. L. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000600016 · Cited by 21

G Protein-Coupled Receptors as Regulators of Energy Homeostasis

Tao, Y., Yuan, Z., & Xie, J. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386933-3.00001-7 · Cited by 21

Microstructure of Eating Behavior Associated With Rorschach Characteristics in Obesity

Elfhag, K., Barkeling, B., Carlsson, A. M., & Rössner, S. (2003) · Journal of Personality Assessment · doi:10.1207/s15327752jpa8101_04 · Cited by 21

Dulaglutide in the treatment of adult type 2 diabetes: a perspective for primary care providers

Anderson, J. E., Thieu, V. T., Boye, K. S., Hietpas, R. T., & García‐Pérez, L. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1218260 · Cited by 22

Expression and purification of exendin-4, a GLP-1 receptor agonist, in Escherichia coli

Yin, X., Wei, D., Yi, L., Tao, X., & Ma, Y. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2004.10.014 · Cited by 21

Differential responses of circulating amylin to high‐fat vs. high‐carbohydrate meal in healthy men

Eller, L. K., Ainslie, P. N., Poulin, M. J., & Reimer, R. A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03129.x · Cited by 20

Circulating glucagon-like peptide-1 increases in response to short-term overfeeding in men

Wadden, D., Cahill, F., Amini, P., Randell, E. W., Vasdev, S., Yi, Y., Church, J. G., & Sun, G. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-33 · Cited by 22

Gut-Brain Neuropeptides in the Regulation of Ingestive Behaviors and Obesity.

Crowell, M. D., Decker, G. A., Levy, R. L., Jeffrey, R., & Talley, N. J. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00832.x · Cited by 21

The Role of Gut Microbiota in Host Lipid Metabolism: An Eye on Causation and Connection

Wang, K., Liang, X., Pang, Y., & Jiang, C. (2019) · Small Methods · doi:10.1002/smtd.201900604 · Cited by 19

Impact of isoenergetic intake of irregular meal patterns on thermogenesis, glucose metabolism, and appetite: a randomized controlled trial

Alhussain, M. H., Macdonald, I. A., & Taylor, M. A. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab323 · Cited by 19

Dipeptidyl‐peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrations

Senmaru, T., Fukui, M., Kobayashi, K., Iwase, H., Inada, S., Okada, H., Asano, M., Yamazaki, M., Hasegawa, G., Nakamura, N., et al. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00220.x · Cited by 19

Glucagon-like peptides 1 and 2

Kissow, H. (2015) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000132 · Cited by 17

Fasting glucagon-like peptide 1 concentration is associated with lower carbohydrate intake and increases with overeating

Basolo, A., Heinitz, S., Stinson, E. J., Begaye, B., Hohenadel, M. G., Piaggi, P., Krakoff, J. A., & Votruba, S. B. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0954-5 · Cited by 17

Characteristics and food consumption for current, previous, and potential consumers of GLP-1 s

Dilley, A., Adhikari, S., Silwal, P., L. Lusk, J., & McFadden, B. R. (2025) · Food Quality and Preference · doi:10.1016/j.foodqual.2025.105507 · Cited by 18

Proglucagon-derived peptides: human physiology and therapeutic potential

Gasbjerg, L. S., Nielsen, C. K., Suppli, M. P., Grøndahl, M. F. G., Holst, J. J., Knop, F. K., Jeppesen, P. B., & Lund, A. (2025) · Physiological Reviews · doi:10.1152/physrev.00057.2024 · Cited by 19

Mucosal and hormonal adaptations after Roux-en-Y gastric bypass

Feris, F., MCRAE, A. N., Kellogg, T. A., McKenzie, T. J., Ghanem, O. M., & Acosta, A. J. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.08.020 · Cited by 18

The effects of two different hypocaloric diets on glucagon-like peptide 1 in obese adults, relation with insulin response after weight loss

de Luis, D. A., Sagrado, M. G., Conde, R., Aller, R., & Izaola, O. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2007.12.006 · Cited by 17

Effect of Administration Time of Exenatide on Satiety Responses, Blood Glucose, and Adverse Events in Healthy Volunteers

Pinelli, N. R., Jantz, A. S., Smith, Z., Abouhassan, A., Ayar, C., Jaber, N. A., Clarke, A. W., Commissaris, R. L., & Jaber, L. A. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010367653 · Cited by 17

Incretin Therapies: Effects Beyond Glycemic Control

Mudaliar, S. R. D., & Henry, R. R. (2009) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2009.05.010 · Cited by 18

The Role of the Gastrointestinal Tract in Satiation, Satiety, and Food Intake

Peters, H. P. F., & Mela, D. J. (2008) · CRC Press eBooks · doi:10.1201/9781420047844.ch10 · Cited by 15

Expected values for gastrointestinal and pancreatic hormone concentrations in healthy volunteers in the fasting and postprandial state

Meek, C. L., Lewis, H. B., Burling, K., Reimann, F. M., & Gribble, F. M. (2020) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563220975658 · Cited by 15

Medicinal Chemistry of Glucagon-Like Peptide Receptor Agonists

Jones, L. H., & Price, D. A. (2013) · Progress in medicinal chemistry · doi:10.1016/b978-0-444-62652-3.00002-8 · Cited by 15

Dietary Synergies in Appetite Control: Distal Gastrointestinal Tract

Woods, S. C. (2006) · Obesity · doi:10.1038/oby.2006.301 · Cited by 15

Appetite Control across the Lifecourse: The Acute Impact of Breakfast Drink Quantity and Protein Content. The Full4Health Project

Crabtree, D. R., Buosi, W., Fyfe, C., Horgan, G. W., Μanios, Y., Androutsos, O., Giannopoulou, A., Finlayson, G., Beaulieu, K., Meek, C. L., et al. (2020) · Nutrients · doi:10.3390/nu12123710 · Cited by 14

Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.

Hare, K. J. (2010) · PubMed · Cited by 14

Glucagon-Like Peptide-1

Hellström, P. M. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00012-6 · Cited by 14

Exenatide: Its position in the treatment of type 2 diabetes

Guerci, B., & Martin, C. S. (2008) · Annales d Endocrinologie · doi:10.1016/j.ando.2008.03.004 · Cited by 14

The Universal Eating Monitor (UEM): objective assessment of food intake behavior in the laboratory setting

Kissileff, H. R. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01089-0 · Cited by 13

Gut peptide hormones: Importance for food intake

Näslund, E. B., Schmidt, P. T., & Hellström, P. M. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410010634 · Cited by 13

Using the Lymph Fistula Rat Model to Study Incretin Secretion

Yoder, S. M., Kindel, T. L., & Tso, P. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00008-4 · Cited by 14

Peptide YY3-36 and glucagon-like peptide-1 in functional dyspepsia. Secretion and role in symptom generation

Witte, A.-B., Hilsted, L. M., Holst, J. J., & Schmidt, P. T. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1101780 · Cited by 13

Is a model useful in exploring the catabolic mechanisms of weight loss after gastric bypass in humans?

Kirchner, H., Guijarro, A. I., & Meguid, M. M. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3281e2c9e7 · Cited by 13

An overview of the central control of weight regulation and the effect of antipsychotic medication

Tighe, S., & Dinan, T. G. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105058679 · Cited by 14

Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don’t

Novikoff, A., & Müller, T. D. (2024) · Physiology · doi:10.1152/physiol.00032.2023 · Cited by 13

Glucagon‐Like Peptide‐1 Regulation of Carbohydrate Intake Is Differentially Affected by Obesogenic Diets

Pritchett, C. E., & Hajnal, A. S. (2011) · Obesity · doi:10.1038/oby.2011.342 · Cited by 12

Fiber intake Inconsistently Alters Gut Hormone Levels in Humans Following Acute or Chronic Intake

Klosterbuer, A. S., Greaves, K. A., & Slavin, J. L. (2012) · Journal of Food Research · doi:10.5539/jfr.v1n2p255 · Cited by 12

Hormone-based therapies in the regulation of fuel metabolism and body weight

Kesty, N. C., Roth, J. D., & Maggs, D. G. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.11.1733 · Cited by 12

Patient Selection and the Physiology of Gastrointestinal Antiobesity Operations

Näslund, E. B., & Kral, J. G. (2005) · Surgical Clinics of North America · doi:10.1016/j.suc.2005.03.006 · Cited by 12

Management of Obesity in Adults

SKOLNIK, N., & Ryan, D. H. (2014) · Cited by 12

Glycemia Targeted Specialized Nutrition (GTSN) improves postprandial glycemia and GLP-1 with similar appetitive responses compared to a healthful whole food breakfast in persons with type 2 diabetes: a randomized, controlled trial

Devitt, A. A., Oliver, J. S., Hegazi, R. A. F., & Mustad, V. A. (2012) · journal of Diabetes Research and Clinical Metabolism · doi:10.7243/2050-0866-1-20 · Cited by 12

Neural and Hormonal Controls of Food Intake and Satiety

Moran, T. H. (2006) · Elsevier eBooks · doi:10.1016/b978-012088394-3/50037-4 · Cited by 12

Incretin-based therapy: a new horizon in diabetes management

Zarei, M., Vaighan, N. S., Farjoo, M. H., Talebi, S., & Zarei, M. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01479-3 · Cited by 12

Glucagon‐Like Peptide‐1 Links Ingestion, Homeostasis, and the Heart

Krieger, J., Daniels, D., Lee, S. J., Mastitskaya, S., & Langhans, W. (2024) · Comprehensive physiology · doi:10.1002/cph4.7 · Cited by 14

Insulin detemir enhances proglucagon gene expression in the intestinal L cells via stimulating β-catenin and CREB activities

Liu, S., Liu, R., Chiang, Y., Song, L., Li, X., Jin, T., & Wang, Q. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00328.2011 · Cited by 11

Obesity management for cardiovascular disease prevention

Hritani, R., Rifai, M. A., Mehta, A., & German, C. A. (2023) · Obesity Pillars · doi:10.1016/j.obpill.2023.100069 · Cited by 13

Development of innovative tools for investigation of nutrient-gut interaction

Huang, W., Xie, C., Young, R. L., Zhao, J., Ebendorff‐Heidepriem, H., Jones, K. L., Rayner, C. K., & Wu, T. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i25.3562 · Cited by 11

True

Flint, A., Raben, A., Astrup, A. V., Ersbøll, A. K., & Holst, J. J. (2001) · International Journal of Obesity · doi:10.1038/sj/ijo/0801627

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci990 · Cited by 1,402

The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

Flint, A., Raben, A., Ersbøll, A., Holst, J., & Astrup, A. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801627 · Cited by 384

Rapid Publication Glucagon-like Peptide 1 Promotes Satiety and Suppresses Energy Intake in Humans

Invest, J. C., Flint, A., Raben, A., Astrup, A., & Holst, J. J. (2016)

Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men

Näslund, E. B., Gutniak, M., Skogar, S., Rössner, S., & Hellström, P. M. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.3.525 · Cited by 304